| Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of … N Galie, MM Hoeper, M Humbert, A Torbicki, JL Vachiery, JA Barbera, ... European heart journal 30 (20), 2493-2537, 2009 | 5679 | 2009 |
| 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy: the task force for the management of cardiovascular diseases during pregnancy of the … V Regitz-Zagrosek, JW Roos-Hesselink, J Bauersachs, ... European heart journal 39 (34), 3165-3241, 2018 | 3938 | 2018 |
| Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of … Authors/Task Force Members, A Torbicki, A Perrier, S Konstantinides, ... European heart journal 29 (18), 2276-2315, 2008 | 3488 | 2008 |
| ESC Guidelines for the management of grown-up congenital heart disease (new version 2010) The Task Force on the Management of Grown-up Congenital Heart Disease of the European … Endorsed by the Association for European Paediatric Cardiology (AEPC), ... European heart journal 31 (23), 2915-2957, 2010 | 2673 | 2010 |
| The revised Ghent nosology for the Marfan syndrome BL Loeys, HC Dietz, AC Braverman, BL Callewaert, J De Backer, ... Journal of medical genetics 47 (7), 476-485, 2010 | 2428 | 2010 |
| Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology Endorsed by the European Society of Intensive Care Medicine (ESICM), ... European heart journal 26 (4), 384-416, 2005 | 1752 | 2005 |
| 2020 ESC Guidelines for the management of adult congenital heart disease: the Task Force for the management of adult congenital heart disease of the European Society of … H Baumgartner, J De Backer, SV Babu-Narayan, W Budts, M Chessa, ... European heart journal 42 (6), 563-645, 2021 | 1587 | 2021 |
| Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial JR Teerlink, G Cotter, BA Davison, GM Felker, G Filippatos, ... The Lancet 381 (9860), 29-39, 2013 | 1042 | 2013 |
| Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study P Jourdain, G Jondeau, F Funck, P Gueffet, A Le Helloco, E Donal, ... Journal of the American College of Cardiology 49 (16), 1733-1739, 2007 | 948 | 2007 |
| Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society … M Gheorghiade, F Follath, P Ponikowski, JH Barsuk, JEA Blair, ... European journal of heart failure 12 (5), 423-433, 2010 | 804 | 2010 |
| Heterozygous TGFBR2 mutations in Marfan syndrome T Mizuguchi, G Collod-Beroud, T Akiyama, M Abifadel, N Harada, ... Nature genetics 36 (8), 855-860, 2004 | 790 | 2004 |
| Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study L Faivre, G Collod-Beroud, BL Loeys, A Child, C Binquet, E Gautier, ... The American Journal of Human Genetics 81 (3), 454-466, 2007 | 608 | 2007 |
| Multimodality imaging of diseases of the thoracic aorta in adults: from the American Society of Echocardiography and the European Association of Cardiovascular Imaging … SA Goldstein, A Evangelista, S Abbara, A Arai, FM Asch, LP Badano, ... Journal of the American Society of Echocardiography 28 (2), 119-182, 2015 | 604 | 2015 |
| Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study O Milleron, R Pillière, A Foucher, F de Roquefeuil, P Aegerter, G Jondeau, ... European heart journal 25 (9), 728-734, 2004 | 576 | 2004 |
| Mutations in STAT3 and IL12RB1 impair the development of human IL-17–producing T cells L de Beaucoudrey, A Puel, O Filipe-Santos, A Cobat, P Ghandil, ... The Journal of experimental medicine 205 (7), 1543-1550, 2008 | 499 | 2008 |
| Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes M Metra, G Cotter, BA Davison, GM Felker, G Filippatos, BH Greenberg, ... Journal of the American College of Cardiology 61 (2), 196-206, 2013 | 498 | 2013 |
| Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure SD Katz, L Biasucci, C Sabba, JA Strom, G Jondeau, M Galvao, ... Journal of the American College of Cardiology 19 (5), 918-925, 1992 | 476 | 1992 |
| Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure DJ van Veldhuisen, F Braunschweig, V Conraads, I Ford, MR Cowie, ... Circulation 124 (16), 1719-1726, 2011 | 473 | 2011 |
| Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials JJV McMurray, JR Teerlink, G Cotter, RC Bourge, JGF Cleland, ... Jama 298 (17), 2009-2019, 2007 | 400 | 2007 |
| TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome C Boileau, DC Guo, N Hanna, ES Regalado, D Detaint, L Gong, M Varret, ... Nature genetics 44 (8), 916-921, 2012 | 396 | 2012 |
